Freelance science and health journalist with lots of experience writing about all aspects of life sciences and biotech. Recovering geneticist and evolutionary biologist. I am half German and half British and spend most of my time in Berlin while not hiding out in the Norfolk countryside in the UK. When not writing or editing, I like to spend my time taking photos, knitting, reading fiction, eating and making good food and travelling (when global conditions allow!).

Articles by Helen Albert

Alnylam Gets Second RNAi Drug Approval from EMA

Evonetix Raises €27M Series B to Progress DNA Synthesis Technology

Bicycle Therapeutics Partners Genentech in Deal Worth €1.6B

Adrenomed’s Antibody Drug Scores Hit in Phase II Septic Shock Trial


OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology

In Depth 11 Feb 2020

Why European Biotechs Should Look to China for Investment

Expert Advice 6 Feb 2020

Why a Big Pharma Background Can Give Biotech Leaders an Edge

10 Scientists Behind Modern Biotech You Probably Don’t Know

BioNTech Expands Cancer Portfolio With US Biotech Acquisition

Expert Advice 15 Jan 2020

How to Spot a Biotech Winner: Investment Lessons from Sofinnova